학술논문

The microtubule inhibitor eribulin demonstrates efficacy in platinum-resistant and refractory high-grade serous ovarian cancer patient-derived xenograft models
Document Type
Article
Source
In: Therapeutic Advances in Medical Oncology. (Therapeutic Advances in Medical Oncology, January-December 2023, 15)
Subject
Language
English
ISSN
17588359
17588340